IN2014DN06966A - - Google Patents
Info
- Publication number
- IN2014DN06966A IN2014DN06966A IN6966DEN2014A IN2014DN06966A IN 2014DN06966 A IN2014DN06966 A IN 2014DN06966A IN 6966DEN2014 A IN6966DEN2014 A IN 6966DEN2014A IN 2014DN06966 A IN2014DN06966 A IN 2014DN06966A
- Authority
- IN
- India
- Prior art keywords
- relates
- pregabalin
- preparation
- pharmaceutically acceptable
- same
- Prior art date
Links
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN6966DEN2014 IN2014DN06966A (ja) | 2012-01-30 | 2013-01-29 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN250DE2012 | 2012-01-30 | ||
IN252DE2012 | 2012-01-30 | ||
PCT/IB2013/050764 WO2013114283A1 (en) | 2012-01-30 | 2013-01-29 | Gastroretentive tablets |
IN6966DEN2014 IN2014DN06966A (ja) | 2012-01-30 | 2013-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN06966A true IN2014DN06966A (ja) | 2015-04-10 |
Family
ID=48014113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6966DEN2014 IN2014DN06966A (ja) | 2012-01-30 | 2013-01-29 |
Country Status (7)
Country | Link |
---|---|
US (1) | US9393205B2 (ja) |
EP (1) | EP2809304A1 (ja) |
AU (1) | AU2013213769A1 (ja) |
CA (1) | CA2863376A1 (ja) |
IN (1) | IN2014DN06966A (ja) |
WO (1) | WO2013114283A1 (ja) |
ZA (1) | ZA201405581B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013114281A1 (en) * | 2012-01-30 | 2013-08-08 | Ranbaxy Laboratories Limited | Pregabalin gr tablets |
WO2015114509A1 (en) * | 2014-01-28 | 2015-08-06 | Ranbaxy Laboratories Limited | Stabilized gastroretentive tablets of pregabalin |
WO2015174684A1 (ko) * | 2014-05-14 | 2015-11-19 | 동아에스티 주식회사 | 방출제어된 위체류 서방성 제제 |
EP3498260A1 (en) * | 2017-12-12 | 2019-06-19 | Pro.Med.CS Praha A.S. | Oral gastroretentive sustained-release pharmaceutical formulation |
KR20190111784A (ko) | 2018-03-22 | 2019-10-02 | 닛토덴코 가부시키가이샤 | 프레가발린 함유 조성물의 제조 방법 및 프레가발린 함유 조성물 |
WO2019238068A1 (zh) | 2018-06-13 | 2019-12-19 | 北京泰德制药股份有限公司 | 一种普瑞巴林缓释组合物及其制备方法 |
CN111053749B (zh) * | 2018-10-16 | 2022-07-15 | 北京泰德制药股份有限公司 | 一种普瑞巴林缓释组合物及其制备方法 |
CN110974798A (zh) * | 2019-12-19 | 2020-04-10 | 江苏优仿医药科技有限公司 | 药物组合物、缓释片剂及其制备方法 |
CN114796142A (zh) * | 2022-04-08 | 2022-07-29 | 黄山学院 | 萘普生胃漂浮片及其制备方法 |
GB2624861A (en) * | 2022-11-28 | 2024-06-05 | Orbit Pharma Ltd | Sustained release pharmaceutical compositions comprising pregabalin or pharmaceutically acceptable salts thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197819B1 (en) | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
NL2000281C2 (nl) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
EP2217217B1 (en) | 2007-11-23 | 2018-05-30 | Lupin Limited | Controlled release pharmaceutical compositions of pregabalin |
WO2010143052A1 (en) | 2009-06-12 | 2010-12-16 | Micro Labs Limited | Novel pharmaceutical compositions containing pregabalin |
EP2575798B1 (en) | 2010-06-01 | 2017-08-09 | Rubicon Research Private Limited | Gastroretentive dosage forms of gaba analogs |
-
2013
- 2013-01-29 IN IN6966DEN2014 patent/IN2014DN06966A/en unknown
- 2013-01-29 AU AU2013213769A patent/AU2013213769A1/en not_active Abandoned
- 2013-01-29 EP EP13712905.2A patent/EP2809304A1/en not_active Withdrawn
- 2013-01-29 CA CA2863376A patent/CA2863376A1/en not_active Abandoned
- 2013-01-29 WO PCT/IB2013/050764 patent/WO2013114283A1/en active Application Filing
- 2013-01-29 US US14/374,568 patent/US9393205B2/en active Active
-
2014
- 2014-07-29 ZA ZA2014/05581A patent/ZA201405581B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20150025146A1 (en) | 2015-01-22 |
US9393205B2 (en) | 2016-07-19 |
AU2013213769A1 (en) | 2014-08-21 |
CA2863376A1 (en) | 2013-08-08 |
ZA201405581B (en) | 2015-06-24 |
WO2013114283A1 (en) | 2013-08-08 |
EP2809304A1 (en) | 2014-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN06966A (ja) | ||
EP4249055A3 (en) | Tofacitinib oral sustained release dosage forms | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
MX364229B (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
EP3102188A4 (en) | Novel disintegration systems for pharmaceutical dosage forms | |
MX2014004862A (es) | Formulaciones de polimero acrilico. | |
IN2015DN03984A (ja) | ||
PH12016501841A1 (en) | Immunosuppressant formulation | |
PH12014502856B1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
IN2014DN06965A (ja) | ||
MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
IN2013MU01985A (ja) | ||
MX2017015322A (es) | Composicion farmaceutica oral de isotretinoin. | |
IN2013MU01111A (ja) | ||
WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
PH12014502325A1 (en) | Sustained release tablet containing levodropropizine and method for preparing same | |
IN2012DE00826A (ja) | ||
IN2013MU03370A (ja) | ||
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
MX2014010038A (es) | Tabletas dispersables con sabor enmascarado. | |
WO2014013090A3 (en) | Formulation comprising amorphous fingolimod | |
IN2013MU03428A (ja) | ||
IN2013MU02631A (ja) | ||
IN2013MU03426A (ja) | ||
IN2014MU00781A (ja) |